Category: Market

Market

Barclays Issues Equal Weight Rating for Marqeta Inc (MQ) Stock

Barclays has recently reduced Marqeta Inc (MQ) stock to Equal Weight rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 5,

Market

Why Did UBS Give Sunrun Inc (RUN) Stock Buy Rating?

UBS has recently raised Sunrun Inc (RUN) stock to Buy rating, as announced on January 10, 2025, according to Finviz. Earlier, on January 7, 2025,

Market

What’s Driving Nextdecade Corp (NEXT) Stock’s 28.96% Surge Over the Past Month?

TD Cowen has recently reiterated Nextdecade Corp (NEXT) stock to Buy rating, as announced on June 6, 2024, according to Finviz. Earlier, on August 16,

Market

Evercore ISI Just Upgraded Chewy Inc (CHWY) Stock—What Does This Mean for Investors?

Evercore ISI has recently raised Chewy Inc (CHWY) stock rating, as announced on January 13, 2025, according to Finviz. Earlier, on January 6, 2025, Mizuho

Market

Quantum-Si Inc (QSI) Stock: Understanding Its Underlying Value

H.C. Wainwright has recently initiated Quantum-Si Inc (QSI) stock to Buy rating, as announced on December 8, 2023, according to Finviz. Earlier, on September 25,

Market

Unity Software Inc (U) Stock: A Deeper Look at Its True Potential

Wells Fargo has recently initiated Unity Software Inc (U) stock to Equal Weight rating, as announced on October 29, 2024, according to Finviz. Earlier, on

Market

Why Is Mersana Therapeutics Inc (MRSN) Stock Lagging Behind -67.55% from Its 50-Day SMA?

Citigroup has recently resumed Mersana Therapeutics Inc (MRSN) stock to Buy rating, as announced on November 15, 2024, according to Finviz. Earlier, on March 19,

Market

AGNC Investment Corp (AGNC) Stock Sees Market Value Hit $8.46 billion: What Are the Implications?

Wells Fargo has recently raised AGNC Investment Corp (AGNC) stock to Overweight rating, as announced on September 20, 2024, according to Finviz. Earlier, on July

Market

What’s Causing Recursion Pharmaceuticals Inc (RXRX) Stock’s -23.35% Drop Over the Last Six Months?

Morgan Stanley has recently initiated Recursion Pharmaceuticals Inc (RXRX) stock rating, as announced on May 22, 2023, according to Finviz. Earlier, on March 16, 2023,

Market

Ares Capital Corporation (ARCC) Posted – Profit Margin Last Year—Can It Hold Up?

Wells Fargo has recently raised Ares Capital Corporation (ARCC) stock to Overweight rating, as announced on December 12, 2024, according to Finviz. Earlier, on December

BOVNews.com was originated in 2018 as a Company. Our team comprises Analysts and writers with the knowledge and expertise of Stock Markets and other sectors of Finance.

Category: Market

Barclays Issues Equal Weight Rating for Marqeta Inc (MQ) Stock

Why Did UBS Give Sunrun Inc (RUN) Stock Buy Rating?

What’s Driving Nextdecade Corp (NEXT) Stock’s 28.96% Surge Over the Past Month?

Evercore ISI Just Upgraded Chewy Inc (CHWY) Stock—What Does This Mean for Investors?

Quantum-Si Inc (QSI) Stock: Understanding Its Underlying Value

Unity Software Inc (U) Stock: A Deeper Look at Its True Potential

Why Is Mersana Therapeutics Inc (MRSN) Stock Lagging Behind -67.55% from Its 50-Day SMA?

AGNC Investment Corp (AGNC) Stock Sees Market Value Hit $8.46 billion: What Are the Implications?

What’s Causing Recursion Pharmaceuticals Inc (RXRX) Stock’s -23.35% Drop Over the Last Six Months?

Ares Capital Corporation (ARCC) Posted – Profit Margin Last Year—Can It Hold Up?

Quick Links

Categories